… tissues from patients with Alzheimer’s Disease (AD) will help us to understand the pathology
of this disease. In this study, we conducted the first such large systematic analysis to identify …

The increasing prevalence of Alzheimer's disease ( AD ) poses a considerable socio‐economic
challenge. Decades of experimental research have not led to the development of …

We selected twenty genes from the “Top Results” list on the AlzGene database website and
assessed their association with risk of developing Alzheimer’s disease (AD) in a large, …

… of the dementia disease burden. We aimed to present the first detailed analysis of the global
… of dementia as captured by the Global Burden of Diseases, Injuries, and Risk Factors (GBD) …

… of the current systematic review is to evaluate the presence of differences in the systemic …
the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines …

Alzheimer’s disease (AD) is one of the most common neurodegeneration diseases caused
by multiple factors. The mechanistic insight of AD remains limited. To disclose molecular …

The genetic underpinnings of Alzheimer's disease (AD) remain largely elusive despite early
successes in identifying three genes that cause early-onset familial AD (those that encode …

Background Evidence on preventing Alzheimer’s disease (AD) is challenging to interpret
due to varying study designs with heterogeneous endpoints and credibility. We completed a …

Alzheimer's disease (AD) and stroke are common disorders of aging, but the relationship
between these two disorders remains uncertain. Recent evidence recognized that they …

… The systematic review and meta-analysis was then to be … included in our systematic review
and meta-analysis. The rate … analysis of all studies in random effect model. The pooled …